Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment

BACKGROUND AND AIMS: Metformin is an oral anti‐hyperglycemic recommended by the American Diabetes Association (ADA) as a preferred initial pharmacologic agent for type 2 diabetes. Metabolic acidosis is a rare yet severe side effect of it. We examined the association of metformin use and dosage on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Terry Cheuk‐Fung, Chan, Raymond Ngai Chiu, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Liang, Lilian Yan, Hui, Vicki Wing‐Ki, Zhang, Xinrong, Li, Guan‐Lin, Chan, Henry Lik‐Yuen, Wong, Grace Lai‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358231/
https://www.ncbi.nlm.nih.gov/pubmed/34401527
http://dx.doi.org/10.1002/hsr2.352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358231/
https://www.ncbi.nlm.nih.gov/pubmed/34401527
http://dx.doi.org/10.1002/hsr2.352

Ejemplares similares